Want to join the conversation?
Medical device manufacturer $BDX reported a jump in 3Q16 earnings driven by solid revenue growth and continued margin improvement. Net income rose to $390MM or $1.80 per share from $62MM or $0.29 per share last year. Revenues rose 2.5% to $3.2Bil. Adjusted EPS was $2.35, up 14.6% or 19.5% on a currency-neutral basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?